X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
86
PharmaCompass offers a list of Dexchloropheniramine Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dexchloropheniramine Maleate manufacturer or Dexchloropheniramine Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dexchloropheniramine Maleate manufacturer or Dexchloropheniramine Maleate supplier.
PharmaCompass also assists you with knowing the Dexchloropheniramine Maleate API Price utilized in the formulation of products. Dexchloropheniramine Maleate API Price is not always fixed or binding as the Dexchloropheniramine Maleate Price is obtained through a variety of data sources. The Dexchloropheniramine Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CHLORPHENIRAMINE POLISTIREX manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CHLORPHENIRAMINE POLISTIREX, including repackagers and relabelers. The FDA regulates CHLORPHENIRAMINE POLISTIREX manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CHLORPHENIRAMINE POLISTIREX API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CHLORPHENIRAMINE POLISTIREX manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CHLORPHENIRAMINE POLISTIREX supplier is an individual or a company that provides CHLORPHENIRAMINE POLISTIREX active pharmaceutical ingredient (API) or CHLORPHENIRAMINE POLISTIREX finished formulations upon request. The CHLORPHENIRAMINE POLISTIREX suppliers may include CHLORPHENIRAMINE POLISTIREX API manufacturers, exporters, distributors and traders.
click here to find a list of CHLORPHENIRAMINE POLISTIREX suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CHLORPHENIRAMINE POLISTIREX DMF (Drug Master File) is a document detailing the whole manufacturing process of CHLORPHENIRAMINE POLISTIREX active pharmaceutical ingredient (API) in detail. Different forms of CHLORPHENIRAMINE POLISTIREX DMFs exist exist since differing nations have different regulations, such as CHLORPHENIRAMINE POLISTIREX USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CHLORPHENIRAMINE POLISTIREX DMF submitted to regulatory agencies in the US is known as a USDMF. CHLORPHENIRAMINE POLISTIREX USDMF includes data on CHLORPHENIRAMINE POLISTIREX's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CHLORPHENIRAMINE POLISTIREX USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CHLORPHENIRAMINE POLISTIREX suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CHLORPHENIRAMINE POLISTIREX Drug Master File in Korea (CHLORPHENIRAMINE POLISTIREX KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CHLORPHENIRAMINE POLISTIREX. The MFDS reviews the CHLORPHENIRAMINE POLISTIREX KDMF as part of the drug registration process and uses the information provided in the CHLORPHENIRAMINE POLISTIREX KDMF to evaluate the safety and efficacy of the drug.
After submitting a CHLORPHENIRAMINE POLISTIREX KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CHLORPHENIRAMINE POLISTIREX API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CHLORPHENIRAMINE POLISTIREX suppliers with KDMF on PharmaCompass.
A CHLORPHENIRAMINE POLISTIREX CEP of the European Pharmacopoeia monograph is often referred to as a CHLORPHENIRAMINE POLISTIREX Certificate of Suitability (COS). The purpose of a CHLORPHENIRAMINE POLISTIREX CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CHLORPHENIRAMINE POLISTIREX EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CHLORPHENIRAMINE POLISTIREX to their clients by showing that a CHLORPHENIRAMINE POLISTIREX CEP has been issued for it. The manufacturer submits a CHLORPHENIRAMINE POLISTIREX CEP (COS) as part of the market authorization procedure, and it takes on the role of a CHLORPHENIRAMINE POLISTIREX CEP holder for the record. Additionally, the data presented in the CHLORPHENIRAMINE POLISTIREX CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CHLORPHENIRAMINE POLISTIREX DMF.
A CHLORPHENIRAMINE POLISTIREX CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CHLORPHENIRAMINE POLISTIREX CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CHLORPHENIRAMINE POLISTIREX suppliers with CEP (COS) on PharmaCompass.
A CHLORPHENIRAMINE POLISTIREX written confirmation (CHLORPHENIRAMINE POLISTIREX WC) is an official document issued by a regulatory agency to a CHLORPHENIRAMINE POLISTIREX manufacturer, verifying that the manufacturing facility of a CHLORPHENIRAMINE POLISTIREX active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting CHLORPHENIRAMINE POLISTIREX APIs or CHLORPHENIRAMINE POLISTIREX finished pharmaceutical products to another nation, regulatory agencies frequently require a CHLORPHENIRAMINE POLISTIREX WC (written confirmation) as part of the regulatory process.
click here to find a list of CHLORPHENIRAMINE POLISTIREX suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CHLORPHENIRAMINE POLISTIREX as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CHLORPHENIRAMINE POLISTIREX API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CHLORPHENIRAMINE POLISTIREX as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CHLORPHENIRAMINE POLISTIREX and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CHLORPHENIRAMINE POLISTIREX NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CHLORPHENIRAMINE POLISTIREX suppliers with NDC on PharmaCompass.
CHLORPHENIRAMINE POLISTIREX Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CHLORPHENIRAMINE POLISTIREX GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CHLORPHENIRAMINE POLISTIREX GMP manufacturer or CHLORPHENIRAMINE POLISTIREX GMP API supplier for your needs.
A CHLORPHENIRAMINE POLISTIREX CoA (Certificate of Analysis) is a formal document that attests to CHLORPHENIRAMINE POLISTIREX's compliance with CHLORPHENIRAMINE POLISTIREX specifications and serves as a tool for batch-level quality control.
CHLORPHENIRAMINE POLISTIREX CoA mostly includes findings from lab analyses of a specific batch. For each CHLORPHENIRAMINE POLISTIREX CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CHLORPHENIRAMINE POLISTIREX may be tested according to a variety of international standards, such as European Pharmacopoeia (CHLORPHENIRAMINE POLISTIREX EP), CHLORPHENIRAMINE POLISTIREX JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CHLORPHENIRAMINE POLISTIREX USP).
Market Place
